ArthroCare Corp (ARTC)

48.60
0.04 0.08
NASDAQ : Health Care
Prev Close 48.56
Open 48.60
Day Low/High 48.56 / 48.61
52 Wk Low/High 31.56 / 49.95
Volume 916.44K
Avg Volume 553.60K
Exchange NASDAQ
Shares Outstanding 34.50M
Market Cap 1.68B
EPS 0.65
P/E Ratio 110.36
Div & Yield N.A. (N.A)
Bullish Two Hundred Day Moving Average Cross - ARTC

Bullish Two Hundred Day Moving Average Cross - ARTC

In trading on Thursday, shares of ArthroCare Corp. crossed above their 200 day moving average of $34.82, changing hands as high as $34.98 per share.

ArthroCare Corporation Stock Downgraded (ARTC)

ArthroCare Corporation Stock Downgraded (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) has been downgraded by TheStreet Ratings from from a buy to hold.

Ratings Changes Today

Upgrades: None Downgrades: ANH, ARTC, BRK.A, MAS, MT, POM, SLAB, TFX, WTI Initiations: ONVO Read on to get TheStreet Quant Ratings' detailed report:

ARTC Crosses Below Key Moving Average Level

ARTC Crosses Below Key Moving Average Level

In trading on Thursday, shares of ArthroCare Corp. crossed below their 200 day moving average of $34.59, changing hands as low as $34.57 per share.

ArthroCare Reports Second Quarter 2013 Financial Results

ArthroCare Reports Second Quarter 2013 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended June 30, 2013.

ArthroCare Announces Date For Second Quarter 2013 Financial Results Press Release And Conference Call

ArthroCare Announces Date For Second Quarter 2013 Financial Results Press Release And Conference Call

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its second quarter 2013 results on Monday, August 5, 2013.

ArthroCare Announces Acquisition Of ENTrigue Surgical, Inc.

ArthroCare Announces Acquisition Of ENTrigue Surgical, Inc.

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, today announced that it has completed the acquisition of ENTrigue Surgical, Inc.

ArthroCare Corporation Stock Upgraded (ARTC)

ArthroCare Corporation Stock Upgraded (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) has been upgraded by TheStreet Ratings from a hold to buy.

Ratings Changes To Be Publicly Issued on 6/14/13

Upgrades: ARTC, CREG, HRB, OCC Downgrades: ITI, REXI, UMH Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Notable Two Hundred Day Moving Average Cross - ARTC

Notable Two Hundred Day Moving Average Cross - ARTC

In trading on Friday, shares of ArthroCare Corp. crossed below their 200 day moving average of $33.40, changing hands as low as $32.28 per share.

4 Stocks Spiking on Big Volume

4 Stocks Spiking on Big Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Notable Two Hundred Day Moving Average Cross - ARTC

Notable Two Hundred Day Moving Average Cross - ARTC

In trading on Wednesday, shares of ArthroCare Corp. crossed below their 200 day moving average of $32.90, changing hands as low as $32.89 per share.

ArthroCare Corporation Stock Downgraded (ARTC)

ArthroCare Corporation Stock Downgraded (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) has been downgraded by TheStreet Ratings from from a buy to hold.

ArthroCare Announces Participation In Investor Conference

ArthroCare Announces Participation In Investor Conference

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.

ArthroCare® Receives FDA Clearance For SpeedLock® HIP Knotless Fixation Implant

ArthroCare® Receives FDA Clearance For SpeedLock® HIP Knotless Fixation Implant

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.

ArthroCare Reports Fourth Quarter And Full Year 2012 Financial Results

ArthroCare Reports Fourth Quarter And Full Year 2012 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2012.

ArthroCare To Host Conference Call On February 14, 2013

ArthroCare To Host Conference Call On February 14, 2013

ArthroCare Corporation (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to release its fourth quarter and year end 2012 results on Thursday, February 14, 2013.

ArthroCare Announces Participation In Investor Conference

ArthroCare Announces Participation In Investor Conference

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.

4 Plays Soaring on Unusual Volume

4 Plays Soaring on Unusual Volume

That said, remember to combine trend and price action with unusual volume. Put them all together to help you decipher the next big trend for any stock.

ArthroCare Announces Participation In Investor Conference

ArthroCare Announces Participation In Investor Conference

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.

ArthroCare Reports Third Quarter 2012 Financial Results

ArthroCare Reports Third Quarter 2012 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the third quarter ended September 30, 2012.

ArthroCare Announces Date For Third Quarter 2012 Financial Results Press Release And Conference Call

ArthroCare Announces Date For Third Quarter 2012 Financial Results Press Release And Conference Call

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its third quarter 2012 results on Wednesday, October 31, 2012.

ArthroCare Corporation Stock Upgraded (ARTC)

ArthroCare Corporation Stock Upgraded (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) has been upgraded by TheStreet Ratings from a hold to buy.

ArthroCare Corporation Stock Downgraded (ARTC)

ArthroCare Corporation Stock Downgraded (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) has been downgraded by TheStreet Ratings from from a buy to hold.

ArthroCare Announces Participation In Investor Conference

ArthroCare Announces Participation In Investor Conference

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.

ArthroCare Reports Second Quarter 2012 Financial Results

ArthroCare Reports Second Quarter 2012 Financial Results

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the second quarter ended June 30, 2012.

ArthroCare Announces Date For Second Quarter 2012 Financial Results Press Release And Conference Call

ArthroCare Announces Date For Second Quarter 2012 Financial Results Press Release And Conference Call

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its second quarter 2012 results on Wednesday, August 1, 2012.

ArthroCare Corporation Stock Upgraded (ARTC)

ArthroCare Corporation Stock Upgraded (ARTC)

ArthroCare Corporation (Nasdaq:ARTC) has been upgraded by TheStreet Ratings from a hold to buy.

ArthroCare Announces Participation In Investor Conference

ArthroCare Announces Participation In Investor Conference

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.

Company Profile For ArthroCare Corporation

Company Profile For ArthroCare Corporation

ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes.